Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer-Reference-Cited by-同舟云学术

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

Published:2018-11-16 Issue:11 Volume:13 Page:e0207399
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lin Z. Ping^ORCID,Zhu Yong-Lian,Lo Ying-Chun,Moscarelli Jake,Xiong Amy,Korayem Yasmin,Huang Pamela H.,Giri Smith,LoRusso Patricia,Ratner Elena S.

Funder

Discovery To Cure

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference66 articles.

1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD. 2016.

2. Cancer statistics, 2018;RL Siegel;CA Cancer J Clin,2018

3. Shih IeM. Ovarian cancer;KR Cho;Annu Rev Pathol,2009

4. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;A du Bois;J Natl Cancer Inst,2003

5. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results;MJ Piccart;J Natl Cancer Inst,2000

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells;Cancer Cell International;2024-08-12

2. Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer;Frontiers in Oncology;2024-08-02

3. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-10

4. Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib;Cancers;2023-08-01

5. Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1;Cancer Letters;2023-08